Early breast cancer: LHRH agonists show considerable promise

sea-maid submitted, created time 2 months 4 weeks (esciencenews.com)

Women who have had early stage breast cancer surgically removed and whose tumor cells are stimulated by the hormone estrogen can benefit from taking luteinizing hormone releasing hormone (LHRH) antagonists, a Cochrane Systematic Review has concluded. This medication may...

Submit comment | Blog It | Email It | Keywords: women's health leutenizing hormone releasing hormon leutenizing hormone cancer LHRH breast cancer